Clinical trial
The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic Tolerance
NCT00319059 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00319059 |
|---|---|
| Title | The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic Tolerance |
| Official title | The Influence of the 34C>T Variant in the AMPD1 Gene on Individual Susceptibility for Ischemia-reperfusion. |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | ZonMw: The Netherlands Organisation for Health Research and Development |
| Status | Completed |
| Study type | Interventional |
| Conditions | AMPD, Ischemic Tolerance |
| Intervention type | Behavioral, Drug |
| Interventions | systemic administration of 99mTc-HYNIC-Annexin A5, 10 minutes of ischemic handgripping |
| Enrollment | 14 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | Apr 22, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: